Should albumin infusion be done before or after paracentesis (percutaneous abdominal paracentesis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Infusion Should Be Administered After Paracentesis

Albumin should be infused after paracentesis is completed, not before, at a dose of 8 g albumin per liter of ascites removed. 1

Evidence-Based Recommendations for Albumin Administration

Large Volume Paracentesis (>5L)

  • Albumin (as 20% or 25% solution) should be infused after paracentesis of >5L is completed at a dose of 8 g albumin/L of ascites removed 1
  • This timing and dosing has strong evidence and a strong recommendation in clinical guidelines 1, 2
  • The purpose is to prevent post-paracentesis circulatory dysfunction (PICD), which can lead to complications including:
    • Hyponatremia
    • Renal impairment
    • Increased mortality

Smaller Volume Paracentesis (<5L)

  • For paracentesis <5L, albumin can be considered after the procedure in:
    • Patients with acute-on-chronic liver failure (ACLF)
    • Patients at high risk of post-paracentesis acute kidney injury 1, 2
  • The risk of PICD is lower with smaller volume paracentesis, but certain high-risk patients may still benefit from albumin administration

Rationale for Post-Paracentesis Administration

Albumin is administered after paracentesis for several important reasons:

  1. Prevention of PICD: Albumin infusion reduces the odds of PICD by 61% (OR = 0.39,95% CI 0.27–0.55) 2, 3
  2. Timing of volume replacement: The goal is to replace the oncotic pressure lost during fluid removal, which logically should occur after the fluid has been removed
  3. Assessment of total volume: Administering albumin after paracentesis allows precise calculation of the required dose based on the actual volume removed

Clinical Benefits of Proper Albumin Administration

Meta-analysis evidence shows that post-paracentesis albumin administration provides significant benefits compared to alternative treatments 3:

  • 61% reduction in PICD
  • 42% reduction in hyponatremia (OR = 0.58,95% CI 0.39–0.87)
  • 36% reduction in mortality (OR = 0.64,95% CI 0.41–0.98)

Practical Implementation

  1. Complete the paracentesis procedure
  2. Measure the total volume of ascites removed
  3. Calculate albumin dose at 8 g/L of ascites removed
  4. Administer albumin (20% or 25% solution) intravenously after the procedure

Important Considerations and Caveats

  • Volume limitation: Consider limiting paracentesis to less than 8 liters per session to minimize PICD risk 2, 4
  • No need for coagulation testing: Routine measurement of prothrombin time and platelet count before therapeutic or diagnostic paracentesis is not recommended 1
  • Ultrasound guidance: Should be considered when available to reduce adverse events 1
  • Post-procedure monitoring: Patients should be monitored for signs of hypotension during and after paracentesis 2
  • Alternative dosing: Some centers have implemented standardized protocols with slightly lower albumin doses (e.g., 25g for 5-6L, 50g for 7-10L) with similar outcomes 5, but the guideline-recommended dose remains 8g/L

While some studies have investigated lower albumin doses (4g/L) 6, current guidelines still strongly recommend the standard 8g/L dose based on the highest quality evidence and strongest recommendations 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Standardizing the Use of Albumin in Large Volume Paracentesis.

Journal of pharmacy practice, 2020

Research

Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.